# OnCo record 23andme-brca-report (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/23andme-brca-report/>
  a schema:MedicalTest ;
  onco:kind "drug" ;
  schema:identifier "23andme-brca-report" ;
  schema:name "23andMe Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)"@en ;
  schema:description "A saliva test sold directly to the public that looks for a short list of known BRCA1 and BRCA2 changes. A negative result does not rule out an inherited BRCA change, because most such changes are not on the list."@en ;
  schema:url <https://onco.cc/drugs/23andme-brca-report/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN170046>, <https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170046.pdf>, <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K223597> ;
  onco:status "approved" ;
  onco:tag "test", "hereditary" ;
  onco:modality "Direct-to-consumer saliva genetic test (genotyping) for selected BRCA1/BRCA2 variants" ;
  schema:alternateName "23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants)" ;
  onco:approval "US 2018: Over-the-counter report of three BRCA1/BRCA2 variants for adults (De Novo DEN170046)", "US 2023: Report expanded to 44 BRCA1 and BRCA2 variants (510(k) K223597)" ;
  onco:technologies <https://onco.cc/technologies/germline-testing/> ;
  onco:targets <https://onco.cc/targets/brca/> ;
  onco:companies <https://onco.cc/companies/23andme/> ;
  onco:terms <https://onco.cc/terms/gbrca-mutation/>, <https://onco.cc/terms/hereditary-cancer-syndromes/> .